Elizabeth Compton
Women's Health · Richmond, VANPI 1710168224
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$271
- AbbVie$250
- Biogen$151
- Bayer$119
- Exeltis, USA Inc.$108
- Astellas Pharma US Inc$102
- plus $686 from 22 others
What the payments were for
- Food & beverage$1,687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 25 | $271 |
| AbbVie | 11 | $250 |
| Biogen | 7 | $151 |
| Bayer | 8 | $119 |
| Exeltis, USA Inc. | 7 | $108 |
| Astellas Pharma US Inc | 6 | $102 |
| Novo Nordisk | 5 | $81 |
| Myovant Sciences Inc. | 4 | $63 |
| Optumhealth Care Solutions, LLC | 1 | $48 |
| Urovant Sciences Inc | 3 | $48 |
| Therapeuticsmd, Inc. | 3 | $41 |
| Agile Therapeutics, Inc. | 3 | $41 |
| BD | 1 | $38 |
| Coopersurgical, Inc. | 2 | $35 |
| Abbott | 2 | $31 |
| Mycovia Pharmaceuticals, Inc. | 2 | $30 |
| Pfizer | 2 | $29 |
| Scynexis, Inc. | 2 | $29 |
| Mylan Pharmaceuticals Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Organon | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Millicent US Inc | 1 | $17 |
| Merck | 1 | $16 |
| Renovia Inc | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $12 |
How this compares
$1,687 in reported general payments places this provider in the 85th percentile of 188 women's health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $6,276 |
| ValacyclovirValacyclovir Hcl | 11 | $452 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $222 |
| Fluconazole | 27 | $152 |
| Alendronate Sodium | 11 | $142 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $114 |
Paid to pharmacies, not to this prescriber.
Other women's health in Richmond
- Kara ParkerRichmond$10K
- Elizabeth LambRichmond$3K
- Kelly YeongRichmond$3K
- Candice ParkinsRichmond$3K
- Mary CarterRichmond$2K
- Nicole ShaverRichmond$2K
- Tegan FlowersRichmond$1K
- Tricia BeischRichmond$878
- Mary HolmesRichmond$825
- Heather PayneCharlottesville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.